Evidence map›Paper›PMID 40554574›Full record

ArticlePloS one2025

Systematic mediation and interaction analyses of kidney function genetic loci in a general population study.

Dariush Ghasemi-Semeskandeh, David Emmert, Eva König, Luisa Foco, Martin Gögele, Mohamed S Sarhan, Laura Barin, Ryosuke Fujii, Christian Fuchsberger, Dorien J M Peters and 2 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Clinical and Metabolic Signatures ofKidney international reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dariush Ghasemi-SemeskandehDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-4043-815X
David EmmertInstitute for Biomedicine, Eurac Research, Bolzano, Italy.ORCID 0000-0001-8149-1072
Eva KönigInstitute for Biomedicine, Eurac Research, Bolzano, Italy.
Luisa FocoInstitute for Biomedicine, Eurac Research, Bolzano, Italy.
Martin GögeleInstitute for Biomedicine, Eurac Research, Bolzano, Italy.ORCID 0000-0003-4785-4348
Mohamed S SarhanInstitute for Biomedicine, Eurac Research, Bolzano, Italy.ORCID 0000-0003-0904-976X
Laura BarinInstitute for Biomedicine, Eurac Research, Bolzano, Italy.ORCID 0000-0001-8139-4686
Ryosuke FujiiInstitute for Biomedicine, Eurac Research, Bolzano, Italy.
Christian FuchsbergerInstitute for Biomedicine, Eurac Research, Bolzano, Italy.
Dorien J M PetersDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Peter P PramstallerInstitute for Biomedicine, Eurac Research, Bolzano, Italy.
Cristian PattaroInstitute for Biomedicine, Eurac Research, Bolzano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is a complex disease affecting >10% of the global population, with large between- and within-continent variability reflecting major environmental determinants. To identify molecular targets for treatment and prevention, genome-wide association study meta-analyses (GWAMAs) of CKD-defining traits have identified hundreds of genetic loci in aggregated population samples. However, while GWAMAs estimate the average allelic effect across studies, single population studies may be relevant to unravel specific mechanisms. To assess whether a study sample from a specific population could extend existing knowledge on kidney function genetics, we selected 147 kidney function relevant loci identified by a large GWAMA, assessing their association with the glomerular filtration rate estimated from serum creatinine (eGFRcrea) in 10,146 participants to the Cooperative Health Research In South Tyrol (CHRIS) study, conducted in an Alpine region where thyroid dysfunction is common. We identified associations with single nucleotide polymorphisms (SNPs) at 11 loci, showing up-to-5.4 times larger effect sizes than in the corresponding GWAMA, not explainable by allele frequency differences. Systematic mediation analysis across 70 quantitative traits identified serum magnesium and the activated partial thromboplastin time as partial mediators of the eGFRcrea associations at SHROOM3 and SLC34A1, respectively. Given that free triiodothyronine and thyroxine acted as effect modifiers across all loci, we conducted SNP-by-thyroid stimulating hormone (TSH) interaction analyses, identifying significant interactions at STC1: SNPs had larger effects on eGFRcrea at higher TSH levels, possibly reflecting stanniocalcin-1 autocrine and paracrine role. Individual population studies can help characterize genetic associations. The interplay between phenotypes at SHROOM3 and SLC34A1 and the role of thyroid function as a genetic effect modifier warrant further investigations.

Indexed as

Genetic LociKidneyRenal Insufficiency, ChronicAdultAgedCreatinineFemaleGenome-Wide Association StudyGlomerular Filtration RateHumansMaleMiddle AgedPolymorphism, Single NucleotideCreatinine

Identifiers

PMID40554574
PMCPMC12186986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.